The Chemistry and Radiochemistry of Hypoxia-Specific, Radiohalogenated Nitroaromatic Imaging Probes

Bayer, 2011, Acute versus chronic hypoxia: Why a simplified classification is simply not enough, Int J Radiat Oncol Biol Phys, 80, 965, 10.1016/j.ijrobp.2011.02.049 Majmundar, 2010, Hypoxia-inducible factors and the response to hypoxic stress, Mol Cell, 40, 294, 10.1016/j.molcel.2010.09.022 Mimeault, 2013, Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer and metastasis-initiating cells, J Cell Mol Med, 17, 30, 10.1111/jcmm.12004 Raleigh, 1996, Measuring tumor hypoxia, Semin Radiat Oncol, 6, 37, 10.1016/S1053-4296(96)80034-8 Vikram, 2007, Methods for noninvasive imaging of tissue hypoxia, Antioxid Redox Signal, 9, 1745, 10.1089/ars.2007.1717 Horsman, 2012, Imaging hypoxia to improve radiotherapy outcome, Nat Rev Clin Oncol, 9, 674, 10.1038/nrclinonc.2012.171 Lin, 2012, Hypoxia imaging markers and applications for radiation treatment planning, Semin Nucl Med, 42, 343, 10.1053/j.semnuclmed.2012.04.002 Gray, 1953, The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy, Br J Radiol, 26, 638, 10.1259/0007-1285-26-312-638 Adams, 1963, Hydrated electrons and radiobiological sensitisation, Biochem Biophys Res Commun, 12, 473, 10.1016/0006-291X(63)90318-8 Fowler, 1985, Eighth annual Juan del Regato lecture. Chemical modifiers of radiosensitivity-theory and reality: A review, Int J Radiat Oncol Biol Phys, 11, 665, 10.1016/0360-3016(85)90296-2 Wardman, 2007, Chemical radiosensitizers for use in radiotherapy, Clin Oncol (R Coll Radiol), 19, 397, 10.1016/j.clon.2007.03.010 Monney, 1981, Nitroimidazole radiosensitizers: Approaches to their chemical synthesis, Pharmacol Ther, 14, 197, 10.1016/0163-7258(81)90061-9 Adams, 1971, Electron affinic sensitization II. Para-nitroacetophenone: A radiosensitizer for anoxic bacterial and mammalian cells, Int J Radiat Biol Relat Stud Phys Chem Med, 19, 575, 10.1080/09553007114550751 Wardman, 1977, The use of nitroaromatic compounds as hypoxic cell radiosensitizers: A review, Curr Top Radiat Res Q, 11, 347 Nunn, 1995, Nitroimidazoles and imaging hypoxia: A review, Eur J Nucl Med, 22, 265, 10.1007/BF01081524 Adams, 1976, Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers, Radiat Res, 67, 9, 10.2307/3574491 Smeyers, 1981, Theoretical approach for radiosensitizers. Correlation between calculated electroaffinity and sensitization factors of nitro-compounds, Int J Radiat Biol Relat Stud Phys Chem Med, 39, 649, 10.1080/09553008114550771 Beaman, 1967, Studies in the nitroimidazole series. 3. 2-Nitroimidazole derivatives substituted in the 1-position, Antimicrob Agents Chemother, 7, 520 Wiltshire, 1978, Clinical studies with misonidazole, Br J Cancer, 3, 286P Zeman, 1986, SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells, Int J Radiat Oncol Biol Phys, 12, 1239, 10.1016/0360-3016(86)90267-1 Doherty, 1994, Muscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation, Int J Radiat Oncol Biol Phys, 29, 379, 10.1016/0360-3016(94)90293-3 Biaglow, 1986, Biochemistry of reduction of nitro heterocycles, Biochem Pharmacol, 35, 77, 10.1016/0006-2952(86)90561-7 Chapman, 1981, A marker for hypoxic cells in tumours with potential clinical applicability, Br J Cancer, 43, 546, 10.1038/bjc.1981.79 Mees, 2009, Molecular imaging of hypoxia with radiolabelled agents, Eur J Nucl Med Mol Imaging, 36, 1674, 10.1007/s00259-009-1195-9 Apte, 2011, Molecular imaging of hypoxia: Strategies for probe design and application, Curr Org Synth, 8, 593, 10.2174/157017911796117179 Chitneni, 2011, Molecular imaging of hypoxia, J Nucl Med, 52, 165, 10.2967/jnumed.110.075663 Szabo A, Ostlund NS (eds): Modern Quantum Chemistry: Introduction to Advanced Electronic Structure Theory. McGraw Hill, New York, 1989 Yamamoto, 2002, Synthesis and evaluation of 4-bromo-1-(3-[18F]fluoropropyl)-2-nitroimidazole with a low energy LUMO orbital designed as brain hypoxia-targeting imaging agent, Biol Pharm Bull, 25, 616, 10.1248/bpb.25.616 Minchinton, 2006, Drug penetration in solid tumours: A review, Nat Rev Cancer, 6, 583, 10.1038/nrc1893 Brown, 1980, Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole, Radiat Res, 82, 171, 10.2307/3575246 Workman, 1982, Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU, Br J Cancer, 46, 249, 10.1038/bjc.1982.190 Martinez, 2002, A mechanistic approach to understanding the factors affecting drug absorption: A review of fundamentals, J Clin Pharmacol, 42, 620, 10.1177/00970002042006005 Tubis, 1976, Scintigraphic demonstration of amebic liver abscesses with 131iodine labeled bromometronidazole, Nucl Med (Stuttg), 15, 36 Wiebe, 1984, Radionuclides, radiotracers and radiopharmaceuticals for in vivo diagnosis, Radiat Phys Chem, 24, 365, 10.1016/0146-5724(84)90073-6 Wiebe, 2002, Scintigraphic imaging of focal hypoxic tissue: Development and clinical applications of 123I-IAZA, Braz Arch Biol Technol, 45, 69, 10.1590/S1516-89132002000500010 Liang, 2013, Introduction of fluorine and fluorine-containing functional groups, Angew Chem Int Ed Engl, 52, 8214, 10.1002/anie.201206566 Johannes, 2014, 18F-Labelled intermediates for radiosynthesis by modular build-up reactions: Newer developments, Biomed Res Int Jette, 1983, Synthesis and in vivo studies of the radiosensitizer 4-[82Br]bromomisonidazole, Int J Nucl Med Biol, 10, 205, 10.1016/0047-0740(83)90080-3 Norman, 1995, Synthesis and distribution of In-111, Ga-67 and Gd-153-radiolabeled conjugates of nitroimidazoles with bifunctional complexing agents-imaging agents for hypoxia, Supramol Chem, 4, 305, 10.1080/10610279508028940 Nunn, 1995, Nitroimidazoles and imaging hypoxia, Eur J Nucl Med, 22, 265, 10.1007/BF01081524 Bonnitcha, 2010, Nitroimidazole conjugates of bis (thiosemicarbazonato) 64Cu(II)-potential combination agents for the PET imaging of hypoxia, J Inorg Biochem, 104, 126, 10.1016/j.jinorgbio.2009.10.009 Wangler, 2011, Chelating agents and their use in radiopharmaceutical sciences, Mini Rev Med Chem, 11, 968, 10.2174/138955711797068445 Cai, 2008, Chemistry with [18F] fluoride ion: Microreview, Eur J Org Chem, 2853, 10.1002/ejoc.200800114 Chin, 2006, Automated radiosynthesis of [18F] SPA-RQ for imaging human brain NK1 receptors with PET, J Labelled Compounds Radiopharm, 49, 17, 10.1002/jlcr.1016 Briard, 2009, Single-step high-yield radiosynthesis and evaluation of a sensitive 18F-labeled ligand for imaging brain peripheral benzodiazepine receptors with PET, J Med Chem, 52, 688, 10.1021/jm8011855 Block, 1986, No-carrier-added fluorine-18-labelling of aliphatic compounds in high yields via aminopolyether-supported nucleophilic substitution, J Labelled Compounds Radiopharm, 23, 467, 10.1002/jlcr.2580230503 Becaud, 2009, Direct one-step 18F-labelling of peptides via nucleophilic aromatic substitution, Bioconjug Chem, 20, 2254, 10.1021/bc900240z Lee, 2007, Simple and highly efficient synthesis of 3′-deoxy-3′-[18F]fluorothymidine using nucleophilic fluorination catalyzed by protic solvent, Eur J Nucl Med Mol Imaging, 34, 1406, 10.1007/s00259-007-0391-8 Mamat, 2009, Recent applications of click chemistry for the synthesis of radiotracers for molecular imaging, Mini Rev Org Chem, 6, 21, 10.2174/157019309787316148 Bouvet, 2011, Synthesis of hypoxia imaging agent 1-(5-deoxy-5-fluoro-α-d-arabinofuranosyl)-2-nitroimidazole using microfluidic technology, Nucl Med Biol, 38, 235, 10.1016/j.nucmedbio.2010.09.002 Lee, 1999, Synthesis of iodoaminoimidazole arabinoside (IAIA): A potential reductive metabolite of the SPECT imaging agent, iodoazomycin arabinoside (IAZA), Nucleosides Nucleotides, 18, 1995, 10.1080/07328319908044860 Mannan, 1991, Radioiodinated 1-(5-iodo-5-deoxy-beta-d-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): A novel marker of tissue hypoxia, J Nucl Med, 32, 1764 Urtasun, 1996, Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside, Br J Cancer, 27, S209P Parliament, 1992, Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: Preliminary report of a clinical study, Br J Cancer, 65, 90, 10.1038/bjc.1992.17 Chin, 2009, Automated radiosynthesis of [18F]-EF5 for imaging hypoxia in human, J Labelled Compounds Radiopharm, 52, S274P Biskupiak, 1991, Synthesis of an (iodovinyl)misonidazole derivative for hypoxia imaging, J Med Chem, 34, 2165, 10.1021/jm00111a036 Wester, 1979, Radioiodination of aromatic compounds with 123I and 131I by exchange, J Labeled Compounds Radiopharm, 16, 174 Eisenhut, 1982, Simple labelling of omega-phenylfatty acids by iodine isotope exchange, Int J Appl Radiat Isot, 33, 499, 10.1016/0020-708X(82)90002-3 Mangner, 1982, Solid-phase exchange radioiodination of aryl iodides: Facilitation by ammonium sulfate, J Org Chem, 47, 1484, 10.1021/jo00347a022 Weichert, 1986, Radioiodination via isotope exchange in pivalic acid, Applied Radiation and Isotopes, 37, 907, 10.1016/0883-2889(86)90291-1 Stone-Elander, 2007, Microwaving in F-18 chemistry: Quirks and tweaks, Ernst Schering Res Found Workshop, 62, 243, 10.1007/978-3-540-49527-7_9 2005 Elander, 2000, Microwave-enhanced radiochemistry, Chem Soc Rev, 29, 239, 10.1039/a901713e Getvoldsen, 2002, UV monitoring of microwave-heated reactions: A feasibility study, Chemistry, 8, 2255, 10.1002/1521-3765(20020517)8:10<2255::AID-CHEM2255>3.0.CO;2-R Kumar, 2002, Microwave-assisted (radio) halogenation of nitroimidazole-based hypoxia markers, Appl Radiat Isot, 57, 697, 10.1016/S0969-8043(02)00185-9 Kumar, 2014, Microwave-assisted radiosynthesis of the hypoxia marker 1-α-d-(5-deoxy-5-[18F]fluoroarabinofuranosyl)-2-nitroimidazole ([18F]FAZA), Curr Radiopharm, 7, 49, 10.2174/1874471007666140711115620 Jahnisch, 2004, Chemistry in microstructured reactors: A review, Angew Chem Int Ed Engl, 43, 406, 10.1002/anie.200300577 Wang, 2010, Microfluidics for positron emission tomography probe development, Mol Imaging, 9, 175, 10.2310/7290.2010.00027 Yokell, 2012, Microfluidic single vessel production of hypoxia tracer 1H-1-(3-[18F]-fluoro-2-hydroxy-propyl)-2-nitro-imidazole ([18F]-FMISO), Appl Radiat Isot, 70, 2313, 10.1016/j.apradiso.2012.05.022 Kumar, 2005, [131I]Iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: Radiolabelling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice, Nucl Med Biol, 32, 647, 10.1016/j.nucmedbio.2005.04.019 Koh, 1992, Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole, Int J Radiat Oncol Biol Phys, 22, 199, 10.1016/0360-3016(92)91001-4 Kaemaeraeinen, 2004, Preparation of fluorine-18 labeled fluoromisonidazole using two different synthesis methods, J Labelled Compounds Radiopharm, 47, 37, 10.1002/jlcr.795 Adamsen, 2005, A new synthesis of the labelling precursor for [18F]-fluoromisonidazole, J Labelled Compounds Radiopharm, 48, 923, 10.1002/jlcr.1001 Lim, 1993, An efficient radiosynthesis of [18F]fluoromisonidazole, Appl Radiat Isot, 44, 1085, 10.1016/0969-8043(93)90110-V Hwang, 1989, No-carrier-added synthesis of 3-[18F]fluoro-1-(2-nitro-1-imidazolyl)-2-propanol. A potential PET agent for detecting hypoxic but viable tissues, Int J Radiat Appl Instrum A, 40, 117, 10.1016/0883-2889(89)90186-X Lee, 2013, Development of a new precursor-minimizing base control method and its application for the automated synthesis and SPE purification of [18F]fluoromisonidazole ([18F]FMISO), J Labelled Compounds Radiopharm, 56, 731, 10.1002/jlcr.3115 Reischl, 2007, Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA—First small animal PET results, J Pharm Pharm Sci, 10, 203 Yang, 1995, Development of F-18-labeled fluoroerythronitro imidazole as a PET agent for imaging tumor hypoxia, Radiology, 194, 795, 10.1148/radiology.194.3.7862981 Suehiro, 2011, Radiosynthesis of the tumor hypoxia marker [18F]TFMISO via O-[18F]trifluoroethylation reveals a striking difference between trifluoroethyl tosylate and iodide in regiochemical reactivity toward oxygen nucleophiles, Bioorg Med Chem, 19, 2287, 10.1016/j.bmc.2011.02.026 Doss, 2010, Biodistribution and radiation dosimetry of the hypoxia marker 18F-HX4 in monkeys and humans determined by using whole-body PET/CT, Nucl Med Commun, 31, 1016, 10.1097/MNM.0b013e3283407950 Rasey, 1982, Bromomisonidazole: Synthesis and characterization of a new radiosensitizer, Radiat Res, 91, 542, 10.2307/3575891 Grunbaum, 1987, Synthesis and characterization of congeners of misonidazole for imaging hypoxia, J Nucl Med, 28, 68 Yamamoto, 1999, Synthesis and characterization of lipophilic 1-[18F]fluoroalkyl-2-nitroimidazoles for imaging hypoxia, Biol Pharm Bull, 22, 590, 10.1248/bpb.22.590 Wada, 2000, Synthesis of 1-[2-[18F]fluoro-2-(hydroxymethyl)-ethoxy]methyl-2-nitroimidazole ([18F]FENI), a potential agent for imaging hypoxic tissues by PET, J Labelled Compounds Radiopharm, 43, 785, 10.1002/1099-1344(200007)43:8<785::AID-JLCR363>3.0.CO;2-5 Busk, 2013, PET imaging of tumor hypoxia using 18F-labeled pimonidazole, Acta Oncol, 52, 1300, 10.3109/0284186X.2013.815797 Wiebe, 1984, Electron-affinic compounds for labelling hypoxic cells: The synthesis and characterization of 1-[2-(2-iodophenoxy)-ethyl]-2-nitroimidazole, Nuklearmedizin, 23, 63, 10.1055/s-0038-1624171 Chu, 2009, Synthesis and biological evaluation of radioiodinated 2NUBTA as a cerebral ischemia marker, Bioorg Med Chem Lett, 19, 658, 10.1016/j.bmcl.2008.12.052 Li, 2005, Synthesis and in vitro and in vivo evaluation of three radioiodinated nitroimidazole analogues as tumor hypoxia markers, Nucl Med Biol, 32, 225, 10.1016/j.nucmedbio.2005.01.004 Bohn, 2009, Design of silicon-based misonidazole analogues and (18)F-radiolabelling, Nucl Med Biol, 36, 895, 10.1016/j.nucmedbio.2009.06.004 Postema, 2009, Hypoxia imaging using 1-α-d-(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA): The initial results of a Phase I/II study, Eur J Nucl Med Mol Imaging, 36, 1565, 10.1007/s00259-009-1154-5 Kumar, 2010, Synthesis, radiofluorination, and hypoxia-selective studies of FRAZ: A configurational and positional analogue of the clinical hypoxia marker, [18F]-FAZA, Bioorg Med Chem, 18, 2255, 10.1016/j.bmc.2010.01.064 Mannan, 1992, [125I]FIXN Radioiodinated 1-(2-fluoro-4-iodo-2,4-dideoxy-beta-l-xylopyranosyl)-2-nitroimidazole: A novel probe for the noninvasive assessment of tumor hypoxia, Radiat Res, 132, 368, 10.2307/3578246 Jette, 1986, Iodoazomycin riboside (1-(5′-iodo-5′-deoxyribo furanosyl)-2-nitroimidazole), a hypoxic cell marker. I. Synthesis and in vitro characterization, Radiat Res, 105, 169, 10.2307/3576542 Mannan, 1992, Radioiodinated azomycin pyranoside (IAZP): A novel non-invasive marker for the assessment of tumor hypoxia, J Nucl Biol Med, 36, 60 Evans, 2003, Prognostic significance of tumor oxygenation in humans: A review, Cancer Lett, 195, 1, 10.1016/S0304-3835(03)00012-0 Dolbier, 2001, [18F]-EF5, a marker for PET detection of hypoxia: Synthesis of precursor and a new fluorination procedure, Appl Radiat Isot, 54, 73, 10.1016/S0969-8043(00)00102-0 Dubois, 2011, Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging, Proc Natl Acad Sci U S A, 108, 14620, 10.1073/pnas.1102526108 Mahy, 2004, Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3, Eur J Nucl Med Mol Imaging, 31, 1263, 10.1007/s00259-004-1573-2 Laughlin, 1996, Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl)acetamide) in mice bearing subcutaneous EMT6 tumors, J Pharmacol Exp Ther, 277, 1049 Zha, 2011, Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging, Nucl Med Biol, 38, 501, 10.1016/j.nucmedbio.2010.11.001 Tewson, 1997, Synthesis of [F-18]fluoroetanidazole: A potential new tracer for imaging hypoxia, Nucl Med Biol, 24, 755, 10.1016/S0969-8051(97)00135-2 Barthel, 2004, In vivo evaluation of [18F] fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography, Br J Cancer, 90, 2232, 10.1038/sj.bjc.6601862 Patt, 2002, Adduct of 2-[18F]FDG and 2-nitroimidazole as a putative radiotracer for the detection of hypoxia with PET: Synthesis, in vitro- and in vivo-characterization, Appl Radiat Isot, 57, 705, 10.1016/S0969-8043(02)00186-0 Bormans, 2003, (11)C-methyl-d-glucoside, a tracer of the sodium-dependent glucose transporters, J Nucl Med, 44, 1075 Barros, 2009, Kinetic validation of 6-NBDG as a probe for the glucose transporter GLUT1 in astrocytes, J Neurochem, 109, 94P, 10.1111/j.1471-4159.2009.05885.x Kumar, 2012, Design, synthesis, and preliminary biological evaluation of 6-O-glucose-azomycin adducts for diagnosis and therapy of hypoxic tumors, J Med Chem, 55, 6033, 10.1021/jm2017336 Wuest, 2012, In vitro and in vivo evaluation of [18F]F-GAZ, a novel oxygen-mimetic azomycin-glucose conjugate, Cancer Biother Radiopharm, 27, 473, 10.1089/cbr.2011.1148 Schneider, 1997, The synthesis and radiolabelling of novel markers of tissue hypoxia of the iodinated azomycin nucleoside class, J Labelled Compounds Radiopharm, 39, 541, 10.1002/(SICI)1099-1344(199707)39:7<541::AID-JLCR5>3.0.CO;2-B Riedl, 2008, Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: A comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort, Eur J Nucl Med Mol Imaging, 35, 39, 10.1007/s00259-007-0522-2 Li, 2008, Targeted delivery of macromolecular drugs: Asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development, Curr Drug Deliv, 5, 299, 10.2174/156720108785915069 Bejot, 2010, Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET, Nucl Med Biol, 37, 565, 10.1016/j.nucmedbio.2010.03.011 Hayashi, 2011, High-yield automated synthesis of [18F]fluoroazomycinarabinoside ([18F]FAZA) for hypoxia-specific tumor imaging, Appl Radiat Isot, 69, 1007, 10.1016/j.apradiso.2011.02.025 Nandy, 2010, Simple, column purification technique for the fully automated radiosynthesis of [18F]fluoroazomycinarabinoside ([18F]FAZA), Appl Radiat Isot, 68, 1944, 10.1016/j.apradiso.2010.04.011